Nanjing Medlander Medical Stock Operating Margin
| 688273 Stock | 25.20 0.33 1.33% |
Nanjing Medlander Medical fundamentals help investors to digest information that contributes to Nanjing Medlander's financial success or failures. It also enables traders to predict the movement of Nanjing Stock. The fundamental analysis module provides a way to measure Nanjing Medlander's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanjing Medlander stock.
Nanjing | Operating Margin |
Nanjing Medlander Medical Company Operating Margin Analysis
Nanjing Medlander's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Nanjing Medlander Operating Margin | 0.31 % |
Most of Nanjing Medlander's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanjing Medlander Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Nanjing Medlander Medical has an Operating Margin of 0.3067%. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The operating margin for all China stocks is notably lower than that of the firm.
Nanjing Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanjing Medlander's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nanjing Medlander could also be used in its relative valuation, which is a method of valuing Nanjing Medlander by comparing valuation metrics of similar companies.Nanjing Medlander is currently under evaluation in operating margin category among its peers.
Nanjing Fundamentals
| Return On Equity | 0.0776 | ||||
| Return On Asset | 0.0386 | ||||
| Profit Margin | 0.27 % | ||||
| Operating Margin | 0.31 % | ||||
| Current Valuation | 1.58 B | ||||
| Shares Outstanding | 100 M | ||||
| Shares Owned By Insiders | 69.35 % | ||||
| Shares Owned By Institutions | 8.60 % | ||||
| Price To Book | 1.90 X | ||||
| Price To Sales | 6.60 X | ||||
| Revenue | 340.82 M | ||||
| Gross Profit | 376.75 M | ||||
| EBITDA | 105.63 M | ||||
| Net Income | 89.82 M | ||||
| Total Debt | 6.13 M | ||||
| Book Value Per Share | 13.38 X | ||||
| Cash Flow From Operations | 136.91 M | ||||
| Earnings Per Share | 1.03 X | ||||
| Number Of Employees | 481 | ||||
| Beta | -0.11 | ||||
| Market Capitalization | 2.52 B | ||||
| Total Asset | 1.53 B | ||||
| Retained Earnings | 244.7 M | ||||
| Working Capital | 1.04 B | ||||
| Annual Yield | 0.04 % | ||||
| Net Asset | 1.53 B | ||||
| Last Dividend Paid | 1.0 |
About Nanjing Medlander Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanjing Medlander Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanjing Medlander using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanjing Medlander Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Nanjing Stock
Nanjing Medlander financial ratios help investors to determine whether Nanjing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanjing with respect to the benefits of owning Nanjing Medlander security.